JS007

· Shanghai Junshi Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JS007, covering 2025-07-02 to 2025-07-02. Get the full timeline:

Most recent: Clinical Trial Update: JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma [Phase 2]